Navigating Regulatory Challenges in the U.S. Healthcare Market

If you are building a MedTech startup and targeting the U.S. market, guessing your regulatory pathway is not a strategy. This session breaks down device classification and FDA pathways, along with how to communicate early with FDA to confirm strategy, de-risk development, and build investor confidence. We also cover emerging focus areas, including cybersecurity, AI/ML, human factors, and QMS expectations aligned with ISO 13485. Designed specifically for startups, this presentation provides the clarity you need to move from concept to commercialization with fewer surprises.

Register here: Navigating Regulatory Challenges in the U.S. Healthcare Market